Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report)’s share price fell 4.7% during mid-day trading on Tuesday . The stock traded as low as $21.90 and last traded at $22.12. 111,875 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 240,997 shares. The stock had previously closed at […]

Related Keywords

China , Derekj Maetzold , Castle Biosciences , Robertw Baird , Daniel Bradbury , Allspring Global Investments Holdings , China Universal Asset Management Co , Riverpark Advisors , Keycorp , Assetmark Inc , Wuxi Apptec Co , Castle Biosciences Inc , Scotiabank , Nasdaq , Get Free Report , Biosciences Stock Down , Director Daniel Bradbury , Park Advisors , Universal Asset Management , Global Investments Holdings , Wuxi Apptec , Mypath Melanoma , Castle Biosciences Daily ,